Valuation : IDEXX Laboratories, Inc.

Market Cap 43.72B 37.63B 35.32B 32.26B 60.57B 4,160B 61.02B 419B 163B 2,110B 164B 161B 6,983B P/E 2026 *
37.6x
P/E 2027 * 33.2x
Enterprise Value 44.09B 37.95B 35.62B 32.53B 61.08B 4,195B 61.53B 422B 164B 2,128B 166B 162B 7,042B EV / Sales 2026 *
9.33x
EV / Sales 2027 * 8.49x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -

Last Transcript : IDEXX Laboratories, Inc.

1 day+0.31%
1 week-0.50%
Current month-0.43%
1 month-0.43%
3 months-1.78%
6 months-12.41%
Current year-17.71%
1 week 542.01
Extreme 542.01
561.24
1 month 538.2
Extreme 538.2005
624.15
Current year 518.55
Extreme 518.55
726.41
1 year 518.55
Extreme 518.55
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 102.45
Extreme 102.45
769.98
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Date Insider Type Main position Quantity % Market Cap. Importance
20/08/26 Exercice

Chief Financial Officer

616 0.0008%
30/07/26 Free

Director

49 0.0001%
01/06/26 Exercice

Executive/Senior Manager

1,562 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-0.50%-12.94%+8.85% 43.72B
Average +0.31%-0.35%-12.94%+8.85% 43.72B
Weighted average by Cap. +0.31%-0.35%-12.94%+8.85%

Financials

2026 *2027 *
Net sales 4.72B 4.07B 3.82B 3.49B 6.54B 450B 6.59B 45.23B 17.58B 228B 17.74B 17.35B 754B 5.14B 4.42B 4.15B 3.79B 7.12B 489B 7.17B 49.22B 19.13B 248B 19.3B 18.88B 821B
Net income 1.18B 1.01B 952M 870M 1.63B 112B 1.65B 11.29B 4.39B 56.9B 4.43B 4.33B 188B 1.31B 1.13B 1.06B 970M 1.82B 125B 1.83B 12.58B 4.89B 63.44B 4.93B 4.83B 210B
Net Debt 368M 317M 297M 272M 510M 35.02B 514M 3.52B 1.37B 17.76B 1.38B 1.35B 58.77B -97.34M -83.78M -78.64M -71.82M -135M -9.26B -136M -932M -362M -4.7B -365M -358M -15.55B
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
31/08/26 $556.84 +0.33% 627,007
28/08/26 $554.99 +1.82% 340,987
27/08/26 $545.08 -1.51% 340,584
26/08/26 $553.44 +0.62% 349,441
25/08/26 $550.01 -1.70% 385,739
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
554.99USD
Average target price
698.92USD
Spread / Average Target
+25.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDXX Stock